In vitro evaluation of the interactions between acetone extracts of Garcinia kola seeds and some antibiotics

African Journal of Biotechnology

Volumn 7, Issue 11, 2008, Pages 1672-1678

  Sibanda, T ^a   Okoh, A I ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

Author keywords

Antibiotic resistance; Garcinia kola; Interactions; Resistance modifying compounds

Indexed keywords

AMOXICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; GARCINIA KOLA EXTRACT; PENICILLIN G; TETRACYCLINE;

ARTICLE; ASSAY; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; ESCHERICHIA COLI; GARCINIA KOLA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; NONHUMAN; STAPHYLOCOCCUS AUREUS;

GARCINIA KOLA; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 45249095599     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: 10.5897/ajb08.924     Document Type: Article

References (39)

1. Ahmad I, Aqil F (2007). In vitro efficacy of bioactive extracts of 15 medicinal plants against ESβL-producing multidrug-resistant enteric bacteria. Micro. Res.162: 264-275.
2. Al-hebshi N, Al-haroni M, Skaug N (2006). In vitro antimicrobial and resistance-modifying activities of aqueous crude khat extracts against oral microorganisms. Arch Oral Biol. 51: 183-188.
3. Basri DF, Fan SH (2005). The potential of aqueous and acetone extracts of galls of Queercus infectoria as antibacterial agents. Ind. J. Pharm. 37: 26-29.
4. Betoni JEC, Mantovani RP, Barbosa LN, Di-Stasi LC, Fernandes A (2006). Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Mem. Inst. Oswaldo Cruz. 101 no.4.
5. Brook I, Gooch WM, Jenkins SG, Pichichero ME, Reiner SA, Sher L, Yamauchi T (2000). Medical management of acute bacterial sinusitis: Recommendations of a clinical advisory committee on pediatric and adult sinusitis. Ann. Otol. Rhinol. Laryngol. 109: 1-19.
6. British Society for Antimicrobial Chemotherapy (BSAC) and European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2005). Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. pp. 1-21.
7. Cook N (1998). Methicillin resistant Staphylococcus aureus versus the burn patient. Burns 24: 91-98
8. Cushnie TPT, Lamb AJ (2005). Antimicrobial activity of flavonoids. Int. J. Antimic. Agents. 26(5): 343-356.
9. Darwish RM, Aburjai T, Al-Khalil S, Mahafzah A (2002). Screening of antibiotic resistant inhibitors from local plant materials against two different strains of Staphylococcus aureus. J. Ethnopharm. 79: 359-364.
10. Esimone CO, Iroha IR, Ibezim, EC, Okeh CO, Okpana EM (2006). In vitro evaluation of the interaction between tea extracts and penicillin G against Staphylococcus aureus. Afr. J. Biotechnol. 5(11): 1082-1086
11. European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2003). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Micro. Inf. 9(8): 1-7.
12. European Committtee for Antimicrobial Susceptibity Testing (EUCAST) (2000). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin. Micro. Inf. 6(9): 509-515.
13. 3) in rats. Pharmacol. Res. 45(1): 63-68.
14. Fluit AC, Schmitz FJ, Verhoef J, European SENTRY Participants (2001). Multi-resistance to antimicrobial agents for the ten most frequently isolated bacterial pathogens. Int. J. Antimic. Agents 18: 147-160.
15. Han QB, Lee SF, Qiao CF, He ZD, Song JZ, Sun HD, Xu HX (2005). Complete NMR Assignments of the Antibacterial Biflavonoid GB1 from Garcinia kola. Chem. Pharm. Bull. 53(8): 1034-1036.
16. Hooton TM, Blair AD, Turck M, Counts GW (1984). Synergism at clinically attainable concentrations of aminoglycoside and beta-lactam antibiotics. Antimic. Agents Chemo. 26(4): 535-538.
17. Iwu M, Igboko O (1982). Flavonoids of Garcinia kola seeds. J. Nat. Prod., pp. 650-650.
18. Iwu MW, Duncan AR, Okunji CO (1999). New antimicrobials of plant origin. Janick J (ed.), Perspectives on new crops and new uses. ASHS Press, Alexandria, VA., pp. 457-462.
19. Kamatou GPP, Viljoen AM, van Vuuren SF, van Zyl RL (2006). In vitro evidence of antimicrobial synergy between Salvia chamelaeagnea and Leonotis leonurus. S. Afr. J. Bot. 72: 634-636.
20. Kumar A, Schweizer HP (2005). Bacterial resistance to antibiotics: Active efflux and reduced uptake. Adv. Drug Deliv. Rev. 57: 1486-1513.
21. Lee JY, Oh WS, Ko KS, Heo ST, Moon CS, Ki HK, Kiem S, Peck KR, Song JH (2006). Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus. J. Korean Med. Sci. 21: 188-192.
22. Lewis K, Ausubel FM (2006). Prospects for plant-derived antibacterials. Nat. Biotechnol. 24(12): 1504-1507.
23. Mandal S, Mandal MD, Pal NK (2004). Evaluation of combination effect of ciprofloxacin and cefazolin against Salmonella enterica serovar typhi isolates by in vitro methods. Calicut Med J. 2(2): e2.
24. Marquez B, Neuville L, Moreau NJ, Genet JP, Santos AF, Andrade MCC, Sant' Ana AEG (2005). Multidrug resistance reversal agent from Jatropha elliptica. Phytochemical. 66: 1804-1811.
25. Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, Cook P, Wormser GP (1994). Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimic Agents Chemother. 38(6): 1363-1367.
26. Neugebauer KA, Gilliland SE (2005). Antagonistic action of Lactobacillus delbrueckii ssp. lactis RM2-5 toward spoilage Organisms in cottage cheese. J. Dairy Sci. 88: 1335-1341.
27. Odds FC (2003). Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemo. 52(1): 1-1.
28. Oluwatuyi M, Kaatz GW, Gibbons S (2004). Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochem. 65(24): 3249-3254.
29. Pankey G, Ashcraft D, Patel N (2005). In vitro Synergy of Daptomycin plus Rifampin against Enterococcus faecium Resistant to both Linezolid and Vancomycin. Antimicrob. Agents Chemother., 49(12): 5166-5168.
30. Perron GG, Zasloff M, Bell G (2005). Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. 273(1583): 251-256.
31. Rybak MJ, McGrath BJ (1996). Combination antimicrobial therapy for bacterial infections. Guidelines for the clinician. Drugs. 52(3): 390-405.
32. Sato Y, Shibata H, Arai T, Yamamoto A, Okimura Y, Arakaki N, Higuti T (2004). Variation in synergistic activity by flavone and its related compounds on the increased susceptibility of various strains of methicillin-resistant Staphylococcus aureus to β-lactam antibiotics. Int. J. Antimic. Agents 24(3): 226-233.
33. Shibata H, Kondo K, Katsuyama R, Kawazoe K, Sato Y, Murakami K, Takaishi Y, Arakaki N, Higuti T (2005). Alkyl Gallates, Intensifiers of β-Lactam Susceptibility in Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 49(2): 549-555.
34. Smith ECJ, Williamson EM, Wareham N, Kaatz GW, Gibbons S (2007). Antibacterials and modulators of bacterial resistance from the immature cones of Chamaecyparis lawsoniana. Phytochem. 68(2): 210-217.
35. Stapleton PD, Shah S, Anderson JC, Hara Y, Hamilton-Miller JMT, Taylor PW (2004). Modulation of β-lactam resistance in Staphylococcus aureus by catechins and gallates. Int. J. Antimic. Agents. 23(5): 462-467.
36. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K (2000). Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Appl. Biol. Sci. 97(4): 1433-1437.
37. Tegos G, Stermitz FR, Lomovskaya O, Lewis K (2002). Multidrug Pump Inhibitors Uncover Remarkable Activity of Plant Antimicrobials, Antimicrob. Agents Chemother. 46(10): 3133-3141.
38. White RL, Burgess DS, Manduru M, Bosso JA (1996). Comparison of Three Different In Vitro Methods of Detecting Synergy: Time-Kill, Checkerboard, and E test. Antimicrob. Agents Chemother. 40(8): 1914-1918.
39. Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T (2001). Mechanism of synergy between Epigallochatechin gallate and β-Lactams against methicillin resistant Staphylococcus aureus. Antimic. Agents Chemother. 45(6): 1737-1742.